Search

McFarland, J. M., Z. V. Ho, G. Kugener, J. M. Dempster, P. G. Montgomery, J. G. Bryan, J. M. Krill-Burger, et al. 2018. “Improved Estimation of Cancer Dependencies from Large-Scale RNAi Screens Using Model-Based Normalization and Data Integration”. Nat Commun 9: 4610.

McLean, T. W., S. Ringold, D. Neuberg, K. Stegmaier, R. Tantravahi, J. Ritz, H. P. Koeffler, et al. 1996. “TEL/AML-1 Dimerizes and Is Associated With a Favorable Outcome in Childhood Acute Lymphoblastic Leukemia”. Blood 88: 4252-8.

Mootha, V. K., C. M. Lindgren, K. F. Eriksson, A. Subramanian, S. Sihag, J. Lehar, P. Puigserver, et al. 2003. “PGC-1alpha-Responsive Genes Involved in Oxidative Phosphorylation Are Coordinately Downregulated in Human Diabetes”. Nat Genet 34: 267-73.

Stegmaier, K., S. M. Corsello, K. N. Ross, J. S. Wong, D. J. DeAngelo, and T. R. Golub. 2005. “Gefitinib Induces Myeloid Differentiation of Acute Myeloid Leukemia”. Blood 106: 2841-8.

Stieglitz, E., A. N. Taylor-Weiner, T. Y. Chang, L. C. Gelston, Y. D. Wang, T. Mazor, E. Esquivel, et al. 2016. “Corrigendum: The Genomic Landscape of Juvenile Myelomonocytic Leukemia”. Nat Genet 48: 101.

Stover, D. G., H. A. Parsons, G. Ha, S. S. Freeman, W. T. Barry, H. Guo, A. D. Choudhury, et al. 2018. “Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer”. J Clin Oncol 36: 543-53.

Takeyama, K., S. Monti, J. P. Manis, P. Dal Cin, G. Getz, R. Beroukhim, S. Dutt, et al. 2008. “Integrative Analysis Reveals 53BP1 Copy Loss and Decreased Expression in a Subset of Human Diffuse Large B-Cell Lymphomas”. Oncogene 27: 318-22.

Wagner, B. K., T. Kitami, T. J. Gilbert, D. Peck, A. Ramanathan, S. L. Schreiber, T. R. Golub, and V. K. Mootha. 2008. “Large-Scale Chemical Dissection of Mitochondrial Function”. Nat Biotechnol 26: 343-51.

Wei, G., A. A. Margolin, L. Haery, E. Brown, L. Cucolo, B. Julian, S. Shehata, A. L. Kung, R. Beroukhim, and T. R. Golub. 2012. “Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-XL As a Predictor of MCL1 Dependency”. Cancer Cell 21: 547-62.

Wei, G., D. Twomey, J. Lamb, K. Schlis, J. Agarwal, R. W. Stam, J. T. Opferman, et al. 2006. “Gene Expression-Based Chemical Genomics Identifies Rapamycin As a Modulator of MCL1 and Glucocorticoid Resistance”. Cancer Cell 10: 331-42.